NasdaqCM - Delayed Quote USD

The Oncology Institute, Inc. (TOIIW)

Compare
0.0156
0.0000
(0.00%)
At close: January 10 at 4:00:00 PM EST
Loading Chart for TOIIW
DELL
  • Previous Close 0.0156
  • Open 0.0156
  • Bid --
  • Ask --
  • Day's Range 0.0156 - 0.0156
  • 52 Week Range 0.0156 - 0.0156
  • Volume 1,904
  • Avg. Volume --
  • Market Cap (intraday) --
  • Beta (5Y Monthly) 0.62
  • PE Ratio (TTM) --
  • EPS (TTM) -602.0870
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

theoncologyinstitute.com

800

Full Time Employees

--

Fiscal Year Ends

Recent News: TOIIW

View More

Compare To: TOIIW

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: TOIIW

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -19.81%

  • Return on Assets (ttm)

    -19.42%

  • Return on Equity (ttm)

    -125.59%

  • Revenue (ttm)

    361.07M

  • Net Income Avi to Common (ttm)

    -58.51M

  • Diluted EPS (ttm)

    -602.0870

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    46.36M

  • Total Debt/Equity (mrq)

    414.32%

  • Levered Free Cash Flow (ttm)

    -23.95M

Research Analysis: TOIIW

View More

Company Insights: TOIIW

Research Reports: TOIIW

View More

People Also Watch